Introduction

Graphene, the one-atomic 2D sheet of sp2-bonded carbon atoms arranged into honeycomb lattice, is emerged as a rapidly rising star in the field of material science. Since its discovery in 2004, graphene-based material has been making a profound impact in many areas of science and technology due to its remarkable physicochemical properties such as high specific surface area (theoretically, 2,630 m2/g for single-layer graphene), extraordinary electronic properties, strong mechanical strength and excellent thermal and electrical conductivities [13, 2, 30, 1]. One specific branch of graphene research deals with graphene oxide (GO). This can be considered as a precursor for graphene synthesis by either chemical or thermal reduction processes [25, 5]. GO consists of a single layer of graphite oxide and is usually produced by the chemical treatment of graphite through oxidation, with subsequent dispersion and exfoliation in water or suitable organic solvents. Chemically synthesized GO due to its easy and large-scale production, abundant electroactive defects and functional groups, facile surface modification, high surface area, fast electron transfer rate and biocompatibility, has a great potential in the area of electrochemical sensing and biosensing application [36, 11, 7]. The presence of oxygenated functional groups in GO render it strongly hydrophilic and make it highly dispersible in many solvents, including water that allow ease of processing and its modification [32]. The resulting GO-stable dispersion can be subsequently deposited on various conductive substrates in order to make excellent electrodes by means of common methods such as drop-casting, spraying, or spin-coating. In addition, using well-known chemical strategies, these functional groups serve as sites for chemical modification or functionalization of GO, which in turn can be employed to immobilize various electroactive species through covalent or noncovalent bonds for the design of sensitive electrochemical systems. The study of GO-based materials in recent years has been gaining increasing interest due to its facile synthesis, high dispersibility in a range of solvents, capability of coupling electroactive species onto the surface, and unique optical properties for cellular imaging and drug delivery [6, 27].

Electrochemical impedance spectroscopy (EIS) is the study of the resistive and capacitive behavior of the electrode–electrolyte interface in response to a small AC signal whose frequency may be varied over a wide range [14]. EIS is a sensitive, non-destructive and a useful analytical technique extremely sensitive to the biorecognition events happening at the electrode/electrolyte interface [18]. Importantly, EIS has an advantage of label free detection. Usually, labeling of antibody with dye molecules or enzyme (HRP) is used for fluorescence and amperometric sensing, respectively, to achieve high sensitivity. Such labeling processes would not only make experiments relatively complex and expensive, but also affect the binding affinity between the targets and biomolecules to a certain degree. In this regards, EIS provides label free detection with high sensitivity [18, 3, 34, 29].

Aflatoxins (AF) are a group of secondary fungal metabolites that are produced by Aspergillus flavus and Aspergillus parasiticus under certain conditions and are the most widely spread group of toxins resulting in contamination of food products [4]. There are four main aflatoxins: B1, B2, G1, and G2. Among these, AFB1 is known to be most toxic and is responsible for human hepatocellular carcinoma (International Agency for Research on Cancer regards it as a human carcinogen) [9, 4]. Hence, there is an urgent need for availability of a rapid and sensitive detection of AFB1. Tang et al. utilized multifunctional magnetic bead-based electrochemical immunoassay (CoFe2O4 nanoparticle as the core and Prussian blue nanoparticle (PBNP)-doped silica as the shell) for the detection of AFB1 in food. A linear range of 0.05–12 ng/ml was achieved with a detection limit of 6.0 pg/ml [28]. Wang et al. reported a quartz crystal microbalance (QCM)-based biosensor to detect AFB1 with the detection range of 0.3–7.0 ng/ml, using anti-AFB1-functionalized magnetic core–shell Fe3O4/SiO2 composite nanoparticles, where the bio-functionalized nanoparticles were attached to the surface of the QCM probe with an external magnet [31]. Singh et al. have recently reported a carboxylic multiwalled carbon nanotubes-based electrochemical biosensor for the sensitive detection of AFB1. The biosensor shows high sensitivity of 95 μA/(ng/ml)/cm2, a detection limit of 0.08 ng/ml in the linear detection range of 0.25–1.375 ng/ml. Additionally, the biosensor shows a good storage stability (42 days) [20]. This report aims towards the efficient and label free detection of AFB1 using the GO-based biosensing platform (Table 1).

Table 1 Sensing characteristics of the proposed BSA-anti-AFB1/GO/Au based biosensor compared to some of those reported in literature

Materials and Methods

Materials

Graphite powder flakes (45 μm, >99.99 wt.%), monoclonal anti-AFB1 antibody, AFB1, N-ethyl-N-(3-dimethylaminopropyl)carbodiimide (EDC), N-hydroxysuccinimide (NHS) and bovine serum albumin (BSA) have been procured from Sigma-Aldrich.

Synthesis of Graphene Oxide

GO has been synthesized using modified Hummers method [12] with slight modification. In brief, 1.5 g of graphite powder is pre-oxidized by reacting it with the mixture of 40 ml of 98 % H2SO4, 5 g K2S2O8 and 5 g of P2O5 for 4 h at 80 °C. The resulting suspension is washed with deionized water (DW) four to five times and is vacuum-dried at 50 °C. For the further oxidation pre-oxidized graphite is added to mixture of concentrated H2SO4/H3PO4 (180:13) with constant stirring. After 5 min, 9 g of KMnO4 is added to the mixture and the stirring is continued for 15 h at 50 °C. The reaction is stopped after about 15 h and the reactants are allowed to cool at room temperature after which 200 ml of ice has been poured into mixture followed by 1.5 ml of H2O2 (30 %). The fine material from the mixture is separated through U.S. standard testing sieve of pore size 30 μm and finally the filtration is done. The supernatant is discarded and the filtrate is subjected to centrifugation at 5,000 rpm for about 30 min. After that multiple washing of the sediment material has been carried out using distilled water, dilute HCl and ethanol (100 ml of each) followed by centrifugation separation. The final sediment is suspended in 100 ml of ether and is filtered through PTFE membrane with a pore size of 0.45 μm. The semisolid material obtained as GO is vacuum-dried overnight. The solid brown powder as GO is thus obtained.

Preparation of GO/Au Film

Gold electrodes (1.5 × 0.5 cm2) are cleaned with piranha solution (7H2SO4/3H2O2). Ten microlitres of the aqueous GO solution (1 mg/ml) is uniformly spread onto Au electrodes followed by drying at 50 °C in vacuum oven overnight. The resulting GO/Au electrodes have been utilized for the immobilization of antibodies molecules.

Biofunctionalization of GO/Au Electrode Surface with Anti-AFB1

Prior to the covalent immobilization process, COOH group of GO/Au electrode has been activated using EDC as the coupling agent and NHS as an activator [24]. The anti-AFB1 antibody solution (10 μg/ml) is freshly prepared in phosphate buffer saline (PBS; pH 7.4). Then, 10 μl of this solution is uniformly spread on the activated GO/Au electrode surface and is incubated in humid chamber for about 4 h. The covalent interaction occurs via the formation of strong amide (CO–NH) bond between carboxyl group of GO and amino terminal of the anti-AFB1. The anti-AFB1/GO/ITO immunoelectrode is washed with PBS to remove the unbound antibodies molecules. Further the immunoelectrode is treated with BSA solution (1 mg/ml) which acts as a blocking agent for the non-specific active sites present on the electrode surface. The BSA-anti-AFB1/GO/ITO immunoelectrode is then washed with PBS and stored at 4 °C, when not in use.

Results and Discussion

Structural Studies

Figure 1a shows powder X-ray diffraction (XRD) pattern (copper Kα radiation) of GO and in the range of 5–80°. The intense peak seen at 11.3° (7.96 Å) corresponds to the plane (002) and another peak found at 42.1° (2.12 Å) for the reflection plane (001) of GO (curve a). The number of layers (seven) of the GO has been obtained using the Debye–Scherrer equation [19, 22]

Fig. 1
figure 1

a XRD pattern of graphene oxide shows the characteristic peaks at 11.3° corresponding to (002) plane. b Transmission electron micrograph of the graphene oxide indicating wrinkles and folding on the graphene sheets. c Scanning electron micrograph of graphene oxide film deposited onto Au electrode by drop cast method

$$ t=0.89\lambda /{\beta}_{002}\cdot \cos {\theta}_{002} $$
(1)
$$ n=t/{d}_{002}, $$
(2)

where t is thickness, β 002 is the full width at half-maximum (FWHM), n is the number of graphene layers and d 002 is interlayer spacing.

Figure 1b shows the transmission electron micrograph (TEM) of GO. For TEM studies, well suspended GO has been prepared in water and drop casted onto carbon-coated copper grid. The image clearly demonstrates overlapped graphene layers and the folds and wrinkles are clearly visible. Some of the portion appears darker indicating more graphene sheets than the brighter region.

Figure 1c shows the scanning electron micrograph (SEM) of the GO/Au electrode surface, wherein micron sized island of GO sheet instead of a homogeneous layer clearly appears. It implies that the individual graphene sheets stack together to form larger sheets in the form of flake-like structures.

Optical Studies

Figure 2a indicates UV–vis spectroscopic studies of GO that has been carried out in wavelength range of 200–900 nm. The absorption of radiation starts increasing at 350 nm, wherein the maximum absorption has been seen at 226 nm. This may be assigned due to π–π* transition of aromatic C–C bonds in GO. The band gap of GO is found to be 4.3 eV estimated using the Tauc equation [21].

Fig. 2
figure 2

a UV–visible spectra of graphene oxide indicating the maximum absorption seen at 226 nm corresponding to π–π* transition of aromatic C–C bonds. Inset: plot of (αhν)2 versus  for the estimation of optical band gap (4.11 eV). b Raman spectrum of graphene oxide. c X-ray photoelectron spectrum (XPS) of the C1s region of graphene oxide. d FTIR of GO/Au and anti-AFB1/GO/Au film. The additional amide band seen at 3,277 cm−1 and reduction in the intensity of band seen at 2,977 cm−1 confirms the covalent immobilization of the antibody molecules

Figure 2b demonstrates Raman spectra of GO wherein well-defined D, G and 2D bands are observed. The prominent D peak may be seen at 1,348 cm−1, which indicates the presence of disorder in the GO structure. This can be assigned to both the structural disorder (induced by the tears and folding over of the graphene sheets) and the presence of residual oxygen as well as point defects [8]. The G band seen at 1,598 cm−1 represents the planar sp2 bonded carbon of GO. 2D band (overtone of the D band) found at 2,678 cm−1 is due to the second harmonic of D band indicating dispersive character as a function of excitation energy.

Figure 2c shows XPS spectrum of C 1 s region of the synthesized GO. The spectrum has been deconvoluted into the characteristic binding energy peaks using peak fit 1 software. Background subtraction and peak fitting of the spectra have been done using the Shirley function and Gaussian function, respectively. XPS measurements have been carried out in a Perkin Elmer XPS chamber (PHI 1257) with a base pressure of 5 × 10−9 Torr. The chamber is equipped with a dual anode Mg-Kα (energy 1,253.6 eV) and Al-Kα (energy 1,486.6 eV) X-ray source and a high-resolution hemispherical energy analyzer for energy resolved electron detection. An Mg-Kα X-ray source has been used for this study. The samples are sputtered with 4 keV argon ions to remove surface contamination prior to XPS studies. The binding energy peak found at 283.7 eV is assigned to graphitic C–C bond. The binding energy peaks seen at 285.3 and 286.7 eV is due to the hydroxyl (C–OH) and epoxy (C–O) groups, respectively. Furthermore, the binding energy peak seen at 288 and 289.7 eV can be attributed to the carbonyl (C = O) and carboxylic acid (O–C = O) groups present in the samples [23]. Table 2 indicates the binding energy position of the various functional groups, FWHM and the corresponding relative percentage of these groups in the GO. These results indicate that the GO has abundant carboxylic acid functional groups as evident by their high relative atomic percentage (24.1 %). These carboxylic acid groups have been used to bind with amino terminal of the antibodies through the covalent immobilization process.

Table 2 The C 1 s peak position, FWHM and the relative atomic percentage of various functional groups of the synthesized graphene oxide

Figure 2d shows Fourier transform infrared spectra (FTIR) of the (a) GO/Au and (b) anti-AFB1/GO/Au. The bands observed at 968 cm−1 represents the C–H stretching vibrations. The bands seen at 1,058 cm−1 represent the C–O–C stretching vibration of the epoxy group present in the GO. The band seen at 1,245 cm−1 represents the C–OH stretching vibrations of the hydroxyl group. The characteristic band observed at 1,750 cm−1 may be assigned to C = O stretching vibrations of the carboxylic/carbonyl groups present in the GO. The characteristic band seen at 1,597 cm−1 is due to the aromatic C = C stretching vibration, while a band seen at 1,483 cm−1 represents the H–C–H bending vibrations. Further, band at 2,965 cm−1 is due to the O–H stretch of the carboxylic acid group, the intensity of which get reduced after antibody immobilization (curve b). It indicates that the COOH group gets utilized in the formation of amide bond with antibodies molecules. Moreover, the additional band seen at around 3,277 cm−1 represents N–H stretching of the amide A (curve b).

Electrochemical Impedance Spectroscopic Studies

Figure 3a shows the Nyquist plot obtained for bare Au, GO/Au, anti-AFB1/GO/Au and BSA/anti-AFB1/GO/Au electrodes in the PBS containing 5 mM [Fe(CN)6]4−/3 in the frequency range 106–10−1 Hz at biasing potential of 10 mV. The charge transfer process in these electrodes has been investigated by measuring charge transfer resistance (R ct) at the electrode/electrolyte interface. The value of the charge transfer resistance (R ct) depends on the dielectric and insulating features at the electrode/electrolyte interface. It has been observed that magnitude of R ct for Au electrode (312 Ω, curve a) increases to 363 Ω after its modification with GO. It may be attributed to the insulating characteristic of GO that reduces the conductivity of the gold surface (curve b). The R ct value obtained for anti-AFB1/GO/Au been found to enhance significantly up to 968 Ω. It is because the antibody molecules form an insulating layer on the electrode surface and creates hindrance in the electron transfer to the electrode surface. Further, the R ct value, in the case of BSA-treated immunoelectrode (BSA/anti-AFB1/GO/Au), increases to 1,122 Ω. It is because of the fact that BSA acts as blocking agent which blocks most of the non-specific active sites of the immunoelectrode surface.

Fig. 3
figure 3

a EIS (Nyquist plot) of various modified electrodes, obtained in PBS (pH 7.4) containing 5 mM [Fe(CN)6]3−/4−. b EIS response of the BSA-anti-AFB1/GO/Au immunoelectrode obtained as a function of AFB1 concentration. c Calibration plot between the magnitude of the charge transfer resistance (R ct) and AFB1 concentrations (0.5–5 ng ml−1). d Plot of R ct as a function of time indicating good storage stability of the biosensor (5 weeks)

Response Studies

EIS response studies of the BSA-anti-AFB1/GO/Au immunoelectrode have been investigated as a function of AFB1 concentration (0.5–5 ng/ml) using the EIS technique. Figure 3b indicates the Nyquist plot obtained for the immunoelectrode as a function of AFB1 concentration. It has been observed that the charge transfer resistance (R ct) increases with respect to the AFB1 concentration. This is because the formation of antigen–antibody complexes reduces the conductivity of electrode surface and acts as a barrier in the electron transfer process. Figure 3b shows the calibration plot of Rct values obtained for BSA-anti-AFB1/GO/Au immunoelectrode as a function of the AFB1 concentration. The linear variation of the Rct value with AFB1 concentrations (0.5–5 ng ml−1) obeys Eq. 3.

$$ {R}_{ct}\left(\varOmega \right)=783\;\left(\varOmega \right)+319.5\;\left(\varOmega {\mathrm{ng}}^{-1}\mathrm{ml}\right)*\left[\mathrm{concentration}\;\left(\mathrm{ng}\;{\mathrm{ml}}^{-1}\right)\right] $$
(3)

Regression coefficient (R 2) = 0.99.

This GO/Au-based immunosensor shows high sensitivity of 639 Ω ng−1 ml cm−2 and linear detection range as 0.5–5 ng ml−1. The limit of detection has been evaluated using 3σ/m criteria, where σ is the standard deviation and m is the sensitivity of calibration plot, and is found to be 0.23 ng ml−1. The value of the association constant (K a) obtained as 0.46 ng ml−1 using a Hanes–Woolf plot that indicates high affinity of AFB1 towards anti-AFB1. Furthermore, the large available surface area and abundant functional groups (carboxylic) of the graphene sheets provides high loading of anti-AFB1 molecules resulting in wider linear detection range as well as high sensitivity. The storage stability of this BSA-anti-AFB1/GO/Au-based impedimetric biosensor has been investigated by observing the charge transfer resistance (R ct) at a regular interval of 1 week for 5 weeks with 1 ng/ml concentration of AFB1 (Fig. 3d). Results of these studies indicate no significant decrease in the R ct value (within 5 %) even after 5 weeks, revealing its good storage stability. The sensing performance of the proposed BSA-anti-AFB1/GO/Au-based biosensor is summarized in Table 1 along with some of those reported in the literature.

We compared the EIS response of GO-based (BSA-anti-AFB1/GO/Au) immunoelectrodes to that of Au (BSA-anti-AFB1/Au) and graphite (BSA-anti-AFB1/graphite/Au) in order to show the advantage of GO to the other two counterparts, for the detection of AFB1 food toxin. Since both Au and graphite electrode surface have no functional groups, covalent immobilization of AFB1 cannot be achieved. The anti-AFB1 antibody molecules are physically adsorbed on Au as well as graphite electrode surface and then treated with BSA solution (1 mg/ml). Figure S1a shows the EIS response of the BSA-anti-AFB1/Au immunoelectrode obtained as a function of AFB1 concentration. Here, we do not observe any significant change in the Rct value for AFB1 concentrations (0.5, 1 and 2 ng/ml). It has also been observed that above 2 ng/ml AFB1 concentration, the EIS response saturates (Nyquist plots coincide). This may be due to the poor binding affinity of AFB1 and Au. Figure S1b shows EIS response of the BSA-anti-AFB1/graphite/Au immunoelectrode obtained as a function of AFB1 concentration. Figure S1c shows calibration plot between the magnitude of the charge transfer resistance (Rct) and AFB1 concentrations (0.5–4 ng ml−1). However, the response is found to be linear in the range of (1–4 ng/ml) (inset, Fig. S1c)]. The detection sensitivity estimated from the slope of linear calibration plot, in case of BSA-anti-AFB1/graphite/Au immunoelectrode has been estimated as 74 Ω ng−1 ml cm−2, which is lower than that of BSA-anti-AFB1/GO/Au (639 Ω ng−1 ml cm−2). This BSA-anti-AFB1/graphite/Au shows detection limit of 0.7 ng/ml, which is higher than that of BSA-anti-AFB1/GO/Au (0.23 ng/ml). It is also clear that GO-based immuosensor shows a wider linear detection range of 0.5–5 ng/ml as compared to graphite (1–4 ng/ml) and gold (0.5–2 ng/ml) electrodes. So, these studies clearly reveals the advantage of GO to the other two counterparts namely Au and graphite, in terms of sensing characteristics of the biosensor for the detection of food toxin (AFB1).

Conclusions

GO has been synthesized using modified Hummers method and used to form thin film GO/Au electrode. The GO/Au electrode has been utilized for the covalent immobilization of the monoclonal antibody molecules (anti-AFB1) using EDC-NHS protocol. The anti-AFB1/GO/Au immunoelectrode has been successfully used as a label free biosensing platform to detect a range of AFB1 concentration employing EIS. The fabricated impedimetric immunosensor shows wider linear detection range (0.5–5 ng/ml) along with high sensitivity (639 Ω/(ng/ml)/cm2) and good storage stability (5 weeks). In addition, this GO-based biosensing platform may efficiently be utilized for the label free detection of other important food toxins such as aflatoxin M1 and ochratoxin-A.